The Amyloid ß1-40 kit is designed for the simple and rapid quantification of the peptide in cell-based formats.
Feature | Specification |
---|---|
Application | Protein Quantification |
Sample Volume | 5 µL |
The Amyloid ß1-40 kit is designed for the simple and rapid quantification of the peptide in cell-based formats.
Amyloid ß1-40 and ß1-42 peptides are involved in the appearance of Alzheimer's disease symptoms. The production of these two amyloid peptides is regulated by the activity of 2 enzymes, ß and γ secretase, which cleave the amyloid precursor protein. This kit is intended to measure amyloid ß1-40 peptides in cell supernatant or in whole cells. This assay is a fast alternative to ELISA, thanks to the ease-of-use of our Add and Read method.
Application |
Protein Quantification
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Product Group |
Kit
|
Sample Volume |
5 µL
|
Shipping Conditions |
Shipped Ambient
|
Target Class |
Biomarkers
|
Target Species |
Human
|
Technology |
TR-FRET
|
Therapeutic Area |
Neuroscience
|
Unit Size |
500 assay points
|
The HTRF Amyloid ß1-40 assay is a sandwich immunoassay using two monoclonal antibodies that recognize different epitopes within the ß1-40 peptide. One antibody is labelled with Eu3+-Cryptate and the other with XL-665. The assay can be used with whole cells or cell supernatant.
The Amyloid ß1-40 assay features a streamlined protocol with only two incubation steps:
- Cell stimulation by target compounds
- Amyloid ß1-40 detection using HTRF reagents
The antibodies labelled with HTRF donor and acceptor may be pre-mixed and added in a single dispensing step to further speed up the assay procedure. This protocol requires a single 24-hour incubation at 4°C following cell stimulation.
Detection limit: | 13.64 pg/mL |
---|---|
Dynamic range: | 25 to 1600 pg/mL |
Sample compatibility: | Cell-based or cell supernatants |
Specificity: | No cross-reaction with Amyloid ß 1-42 and ß 1-43 |
Are you looking for resources, click on the resource type to explore further.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading...
We are here to answer your questions.